AngioDynamics Q1 Adj. EPS $(0.04) Beats $(0.11) Estimate, Sales $80.915M Beat $80.500M Estimate

AngioDynamics (NASDAQ: ANGO) reported a Q1 adjusted EPS of $(0.04), surpassing the analyst estimate of $(0.11) by 63.64%. This reflects a 60% increase in losses compared to $(0.10) per share from the same period last year. The company's sales reached $80.915 million, exceeding the $80.500 million estimate by 0.52% and marking a 6.87% increase from $75.711 million in the previous year.